NCT00121862View on ClinicalTrials.gov

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2005

Study Completion Date

March 31, 2006

Conditions
Cutaneous Leishmaniasis
Interventions
BIOLOGICAL

Leish-111f + MPL-SE vaccine

Trial Locations (1)

Unknown

Programa de Estudio y Control de Enfermedades Tropicales (PECET), Medellín

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Access to Advanced Health Institute (AAHI)

OTHER

NCT00121862 - Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite | Biotech Hunter | Biotech Hunter